Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 18, 2018

DrugPatentWatch Database Preview

Cipla Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for CIPLA LTD, and what generic and branded alternatives to CIPLA LTD drugs are available?

CIPLA LTD has fifty-seven approved drugs.

There are eight tentative approvals on CIPLA LTD drugs.

Summary for Cipla Ltd

US Patents:	0
Tradenames:	51
Ingredients:	51
NDAs:	57
Drug Master File Entries:	213
Patent Litigation for Cipla Ltd:	See patent lawsuits for Cipla Ltd
PTAB Cases with Cipla Ltd as petitioner:	See PTAB cases with Cipla Ltd as petitioner

Drugs and US Patents for Cipla Ltd

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cipla Ltd	ANASTROZOLE	anastrozole	TABLET;ORAL	091164-001	Jun 28, 2010	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Cipla Ltd	TESTOSTERONE	testosterone	SOLUTION, METERED;TRANSDERMAL	209533-001	Jan 29, 2018	AT	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Cipla Ltd	ALENDRONATE SODIUM	alendronate sodium	TABLET;ORAL	076768-004	Aug 4, 2008	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Cipla Ltd	TENOFOVIR DISOPROXIL FUMARATE	tenofovir disoproxil fumarate	TABLET;ORAL	078800-001	Jan 26, 2018	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School

Express Scripts

Cantor Fitzgerald

Colorcon

Cerilliant

AstraZeneca

Daiichi Sankyo

Cipla

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.